The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy

被引：0
|
作者：
Sen, Saniye
Ustundag, Sedat
Gonlusen, Gulfiliz
Kanter, Mehmet
Dogutan, Haluk
Ciftci, Senturk
机构：
[1] Trakya Univ, Fac Med, Edirne, Turkey
[2] Cukurova Univ, Fac Med, Adana, Turkey
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [1] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [2] Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
    Fried, Linda F.
    Duckworth, William
    Zhang, Jane Hongyuan
    O'Connor, Theresa
    Brophy, Mar
    Emanuele, Nicholas
    Huang, Grant D.
    McCullough, Peter A.
    Palevsky, Paul M.
    Seliger, Stephen
    Warren, Stuart R.
    Peduzzi, Peter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (02): : 361 - 368
  • [3] Design of Combination Angiotensin Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor for Treatment of Diabetic Nephropathy (VA NEPHRON-D)
    Emanuele, Nicholas
    Fried, Linda F.
    Zhang, Jane Hongyuan
    O'Connor, Theresa
    Brophy, Mary
    Huang, Grant D.
    McCullough, Peter A.
    Palevsky, Paul M.
    Seliger, Stephen
    Warren, Stuart R.
    Conner, Todd
    Peduzzi, Peter
    Duckworth, William
    DIABETES, 2010, 59 : A592 - A592
  • [4] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [5] Combination of half doses of angiotensin type 1 receptor antagonist and angiotensin-converting enzyme inhibitor in diabetic nephropathy
    Fujisawa, T
    Ikegami, H
    Ono, M
    Nishino, M
    Noso, S
    Kawabata, Y
    Ogihara, T
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (01) : 13 - 17
  • [6] Renoprotective effect of combination with angiotensin converting enzyme inhibitor and angiotensin receptor blocker in diabetic nephropathy with renal failure.
    Okada, T
    Nakao, T
    Matsumoto, H
    Hidaka, H
    Yoshino, M
    Nagaoka, Y
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 687A - 687A
  • [7] Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ATRB) alone or in combination to reduce blood pressure in diabetic nephropathy
    Banerjee, SK
    Iqbal, MM
    Islam, MN
    Rahman, MH
    Banik, D
    Ahmed, CM
    Islam, MS
    Hassan, MS
    JOURNAL OF HYPERTENSION, 2005, 23 : S380 - S380
  • [8] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [9] Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient
    Jarred, Ghassan
    Kennedy, R. Lee
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2010, 1 (01) : 23 - 28
  • [10] Beneficial Effects of Combination Therapy with Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor on Vascular Endothelial Function
    Satoshi Morimoto
    Kei Maki
    Yasuko Aota
    Takao Sakuma
    Toshiji Iwasaka
    Hypertension Research, 2008, 31 : 1603 - 1610
12345